Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
暂无分享,去创建一个
[1] D. Bostwick,et al. The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. , 1997, Human pathology.
[2] D. Bostwick,et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. , 1995, Cancer research.
[3] N. Konishi,et al. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. , 1995, The American journal of pathology.
[4] D. Bostwick,et al. Atypical Adenomatous Hyperplasia of the Prostate: Relationship with Carcinoma in 217 Whole‐mount Radical Prostatectomies , 1995, The American journal of surgical pathology.
[5] David G. Bostwick,et al. High grade prostatic intraepithelial neoplasia. The most likely precursor of prostate cancer , 1995 .
[6] T. H. van der Kwast,et al. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: Analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias , 1995, Genes, chromosomes & cancer.
[7] Jorma Isola,et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.
[8] T. Visakorpi,et al. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. , 1995, Cancer research.
[9] P. Roy-Burman,et al. Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. , 1995, The American journal of pathology.
[10] M. Bittner,et al. DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] B. Wullich,et al. DNA aneuploidy in prostatic adenocarcinoma: a frequent event as shown by fluorescence in situ DNA hybridization. , 1994, Human pathology.
[12] R. Bookstein,et al. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer , 1994, Genes, chromosomes & cancer.
[13] R. Jenkins,et al. Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. , 1994, The Journal of urology.
[14] D. Bostwick,et al. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. , 1994, The American journal of surgical pathology.
[15] E. Bergstralh,et al. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. , 1994, Cancer research.
[16] W. Sakr,et al. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. , 1994, Cancer research.
[17] D. Bostwick,et al. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. , 1994, Cancer research.
[18] D. Grignon,et al. Allelic loss in locally metastatic, multisampled prostate cancer. , 1994, Cancer research.
[19] P. Scardino,et al. Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features. , 1994, The Journal of urology.
[20] W. Sakr,et al. Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis , 1993, Genes, chromosomes & cancer.
[21] D. Lane,et al. ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation , 1992, Cell.
[22] W. Sakr,et al. Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate. , 1992, The Journal of urology.
[23] E. Liu,et al. Alterations of the P53 gene are associated with the progression of a human prostate carcinoma. , 1992, The Journal of urology.
[24] F. Alt,et al. myc family oncogenes in the development of normal and neoplastic cells. , 1991, Advances in cancer research.
[25] H. Adami,et al. NATURAL HISTORY OF LOCALISED PROSTATIC CANCER A Population-based Study in 223 Untreated Patients , 1989, The Lancet.
[26] T. Stamey,et al. Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. , 1988, American journal of clinical pathology.
[27] D. Bostwick,et al. Prostatic Intra‐Epithelial Neoplasia and Early Invasion in Prostate Cancer , 1987, Cancer.
[28] D. Bostwick,et al. Intraductal dysplasia: a premalignant lesion of the prostate. , 1986, Human pathology.